Meet Us at Phase "Zero"
"The problem is that [testing on animals] hasn't worked, and it's time we stopped dancing around the problem. ... We need to refocus and adapt new methodologies for use in humans to understand disease biology in humans."
— Dr. Elias Zerhouni, formal director of the National Institutes of Health
About the HUMANOID Center of Research Excellence
The HUMANOID Center of Research Excellence (CoRE) is the translational arm for iNetMed's drug discovery pipeline, bringing a new level of personalization into disease modeling and clinical trials, providing the ability to test the efficacy of therapeutics in Phase '0'. Simply put, HUMANOID is creating a blueprint for academic laboratories, biotechs, and the USFDA to deliver on the promise of precision human disease modeling for reducing translational gap in drug discovery.